KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to -$240.0 million.

  • Amgen's Change in Inventory rose 6475.77% to -$240.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 6081.96%. This contributed to the annual value of -$2.5 billion for FY2024, which is 41568.23% down from last year.
  • Latest data reveals that Amgen reported Change in Inventory of -$240.0 million as of Q3 2025, which was up 6475.77% from -$239.0 million recorded in Q2 2025.
  • Amgen's Change in Inventory's 5-year high stood at $241.0 million during Q3 2022, with a 5-year trough of -$806.0 million in Q1 2024.
  • For the 5-year period, Amgen's Change in Inventory averaged around -$151.7 million, with its median value being -$30.0 million (2023).
  • Per our database at Business Quant, Amgen's Change in Inventory surged by 40208.33% in 2022 and then crashed by 230666.67% in 2024.
  • Amgen's Change in Inventory (Quarter) stood at -$50.0 million in 2021, then surged by 282.0% to $91.0 million in 2022, then plummeted by 729.67% to -$573.0 million in 2023, then surged by 43.63% to -$323.0 million in 2024, then grew by 25.7% to -$240.0 million in 2025.
  • Its Change in Inventory was -$240.0 million in Q3 2025, compared to -$239.0 million in Q2 2025 and -$288.0 million in Q1 2025.